The global biological therapy industry is currently experiencing a period of unprecedented growth, driven by breakthrough innovations in treating complex, chronic conditions such as cancer and autoimmune diseases. Biological therapies, or biologics, derived from living organisms, represent a paradigm shift from traditional small-molecule drugs. They command a significant and rapidly...